Vitruvian Partners LLP holds a concentrated book of 8 stocks worth $201.0M as of Q2 2026 (disclosed Aug 10, 2026, a ~41-day 13F lag). This quarter they opened Wise Group PLC and trimmed Hinge Health Inc-A. Their largest long position is Marqeta Inc-A at 55% of the equity book.
Top-heavy: concentrated book
Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.
98% mapped to company sectors
Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.
Estimated $ traded · quarter-end prices, no cost basis
Other tracked managers holding the same core names as Vitruvian Partners LLP
| Manager / fund | Shared names | Their $ in those |
|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 8 / 8 | $332.4M |
| Arax Advisory Partners | 8 / 8 | $367K |
| BlackRock, Inc. | 7 / 8 | $833.0M |
| STATE STREET CORP | 7 / 8 | $370.2M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 7 / 8 | $365.7M |
| VANGUARD CAPITAL MANAGEMENT LLC | 7 / 8 | $331.0M |
| FMR LLC | 7 / 8 | $135.6M |
| MORGAN STANLEY | 7 / 8 | $133.2M |
Ranked by how many of Vitruvian Partners LLP's top 8 disclosed names each fund also holds: a cross-fund conviction signal from the latest 13F of every tracked manager.
Bars show each stock's share of the portfolio. Click a row for its position history.
| # | Security | Value | Shares | % Port | Last move | History |
|---|---|---|---|---|---|---|
| 1 | Marqeta Inc CLASS A COM | $111.3M | 6.85M | 55.4% | —Held | |
| 2 | Hinge Health Inc CL A | $42.0M | 506.6K | 20.9% | ▼−59% Reduced · −743K sh | |
| 3 | Xometry Inc CLASS A COM | $17.5M | 181.2K | 8.7% | ▼−5.6% Reduced · −11K sh | |
| 4 | Cargurus Inc COM CL A | $11.9M | 350.0K | 5.9% | ▼−26% Reduced · −123K sh | |
| 5 | Global E Online Ltd SHS | $7.3M | 210.2K | 3.6% | —Held | |
| 6 | Maxcyte Inc COM | $6.2M | 5.04M | 3.1% | —Held | |
| 7 | Wise Group PLC ORD SHS CLASS A | $3.4M | 281.3K | 1.7% | ▲New New position | |
| 8 | Rxsight Inc COM | $1.3M | 278.9K | 0.7% | —Held |
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/funds/1692590/holdings"
Use Arkolith to show Vitruvian Partners LLP's latest holdings, largest changes, and filing provenance.
As-of date vs the date the SEC received each filing
Holdings from SEC EDGAR 13F-HR filings, updated quarterly, filed up to 45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. Price-derived performance is withheld until the price-source policy and freshness gate are green.